Table of Content

1 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Overview
1.1 Product Overview and Scope of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
1.2 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Segment by Type
1.2.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Value Comparison by Type (2024-2034)
1.2.2 9-Valent
1.2.3 13-Valent
1.2.4 23-Valent
1.2.5 Others
1.3 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Segment by Application
1.3.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Community Clinics
1.3.4 Public Health Agencies
1.3.5 Others
1.4 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size Estimates and Forecasts
1.4.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue 2024-2034
1.4.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales 2024-2034
1.4.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Competition by Manufacturers
2.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Manufacturers (2024-2024)
2.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Average Price by Manufacturers (2024-2024)
2.4 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent, Product Type & Application
2.7 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Competitive Situation and Trends
2.7.1 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Players Market Share by Revenue
2.7.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Retrospective Market Scenario by Region
3.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region: 2024-2034
3.2.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region: 2024-2024
3.2.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region: 2024-2034
3.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Region: 2024-2034
3.3.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Region: 2024-2024
3.3.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Region: 2024-2034
3.4 North America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Facts & Figures by Country
3.4.1 North America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2034)
3.4.3 North America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Facts & Figures by Country
3.5.1 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2034)
3.5.3 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2034)
3.6.3 Asia Pacific Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Facts & Figures by Country
3.7.1 Latin America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2034)
3.7.3 Latin America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2034)
3.8.3 Middle East and Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2024-2034)
4.1.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2024-2024)
4.1.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2024-2034)
4.1.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2024-2034)
4.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Type (2024-2034)
4.2.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Type (2024-2024)
4.2.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Type (2024-2034)
4.2.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Type (2024-2034)
4.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Price by Type (2024-2034)
5 Segment by Application
5.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2024-2034)
5.1.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2024-2024)
5.1.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2024-2034)
5.1.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2024-2034)
5.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Application (2024-2034)
5.2.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Application (2024-2024)
5.2.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Application (2024-2034)
5.2.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Application (2024-2034)
5.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Price by Application (2024-2034)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.1.4 GlaxoSmithKline Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 LG Chem
6.2.1 LG Chem Corporation Information
6.2.2 LG Chem Description and Business Overview
6.2.3 LG Chem Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.2.4 LG Chem Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.2.5 LG Chem Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Merck Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Panacea Biotec
6.4.1 Panacea Biotec Corporation Information
6.4.2 Panacea Biotec Description and Business Overview
6.4.3 Panacea Biotec Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Panacea Biotec Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.4.5 Panacea Biotec Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.5.4 AstraZeneca Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Pfizer Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Shire
6.6.1 Shire Corporation Information
6.6.2 Shire Description and Business Overview
6.6.3 Shire Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Shire Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.7.5 Shire Recent Developments/Updates
6.8 Pnuvax Incorporated
6.8.1 Pnuvax Incorporated Corporation Information
6.8.2 Pnuvax Incorporated Description and Business Overview
6.8.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Pnuvax Incorporated Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.8.5 Pnuvax Incorporated Recent Developments/Updates
6.9 Serum Institute
6.9.1 Serum Institute Corporation Information
6.9.2 Serum Institute Description and Business Overview
6.9.3 Serum Institute Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Serum Institute Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.9.5 Serum Institute Recent Developments/Updates
6.10 Shinogi
6.10.1 Shinogi Corporation Information
6.10.2 Shinogi Description and Business Overview
6.10.3 Shinogi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Shinogi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.10.5 Shinogi Recent Developments/Updates
6.11 Shenzhen Kangtai Biological Products
6.11.1 Shenzhen Kangtai Biological Products Corporation Information
6.11.2 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Description and Business Overview
6.11.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.11.5 Shenzhen Kangtai Biological Products Recent Developments/Updates
6.12 SK Bioscience
6.12.1 SK Bioscience Corporation Information
6.12.2 SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Description and Business Overview
6.12.3 SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.12.4 SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.12.5 SK Bioscience Recent Developments/Updates
6.13 Walvax Biotechnology
6.13.1 Walvax Biotechnology Corporation Information
6.13.2 Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Description and Business Overview
6.13.3 Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.13.5 Walvax Biotechnology Recent Developments/Updates
6.14 Eli Lilly
6.14.1 Eli Lilly Corporation Information
6.14.2 Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Description and Business Overview
6.14.3 Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.14.5 Eli Lilly Recent Developments/Updates
6.15 Abera
6.15.1 Abera Corporation Information
6.15.2 Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Description and Business Overview
6.15.3 Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.15.5 Abera Recent Developments/Updates
6.16 Sanofi
6.16.1 Sanofi Corporation Information
6.16.2 Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Description and Business Overview
6.16.3 Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.16.5 Sanofi Recent Developments/Updates
6.17 Genentech
6.17.1 Genentech Corporation Information
6.17.2 Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Description and Business Overview
6.17.3 Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Portfolio
6.17.5 Genentech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Industry Chain Analysis
7.2 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Production Mode & Process
7.4 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales and Marketing
7.4.1 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Channels
7.4.2 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Distributors
7.5 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Customers
8 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Dynamics
8.1 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Industry Trends
8.2 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Drivers
8.3 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Challenges
8.4 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Competitive Situation by Manufacturers in 2022
Table 4. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent, Product Type & Application
Table 12. Global Key Manufacturers of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polyvalent Streptococcus Pneumoniae Active Immunizing Agent as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region (2024-2024) & (K Units)
Table 18. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Region (2024-2024)
Table 19. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region (2024-2034) & (K Units)
Table 20. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Region (2024-2034)
Table 21. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Region (2024-2024)
Table 23. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Region (2024-2034)
Table 25. North America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2024) & (K Units)
Table 27. North America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2034) & (K Units)
Table 28. North America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2024) & (K Units)
Table 32. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2034) & (K Units)
Table 33. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units) by Type (2024-2024)
Table 51. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units) by Type (2024-2034)
Table 52. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2024-2024)
Table 53. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2024-2034)
Table 54. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Type (2024-2024)
Table 57. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Type (2024-2034)
Table 58. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Price (US$/Unit) by Type (2024-2024)
Table 59. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Price (US$/Unit) by Type (2024-2034)
Table 60. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units) by Application (2024-2024)
Table 61. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units) by Application (2024-2034)
Table 62. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2024-2024)
Table 63. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2024-2034)
Table 64. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Application (2024-2024)
Table 67. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Application (2024-2034)
Table 68. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Price (US$/Unit) by Application (2024-2024)
Table 69. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Price (US$/Unit) by Application (2024-2034)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. GlaxoSmithKline Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. LG Chem Corporation Information
Table 76. LG Chem Description and Business Overview
Table 77. LG Chem Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. LG Chem Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 79. LG Chem Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Merck Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 84. Merck Recent Developments/Updates
Table 85. Panacea Biotec Corporation Information
Table 86. Panacea Biotec Description and Business Overview
Table 87. Panacea Biotec Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Panacea Biotec Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 89. Panacea Biotec Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. AstraZeneca Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Pfizer Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Shire Corporation Information
Table 101. Shire Description and Business Overview
Table 102. Shire Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Shire Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 104. Shire Recent Developments/Updates
Table 105. Pnuvax Incorporated Corporation Information
Table 106. Pnuvax Incorporated Description and Business Overview
Table 107. Pnuvax Incorporated Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Pnuvax Incorporated Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 109. Pnuvax Incorporated Recent Developments/Updates
Table 110. Serum Institute Corporation Information
Table 111. Serum Institute Description and Business Overview
Table 112. Serum Institute Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Serum Institute Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 114. Serum Institute Recent Developments/Updates
Table 115. Shinogi Corporation Information
Table 116. Shinogi Description and Business Overview
Table 117. Shinogi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Shinogi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 119. Shinogi Recent Developments/Updates
Table 120. Shenzhen Kangtai Biological Products Corporation Information
Table 121. Shenzhen Kangtai Biological Products Description and Business Overview
Table 122. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 124. Shenzhen Kangtai Biological Products Recent Developments/Updates
Table 125. SK Bioscience Corporation Information
Table 126. SK Bioscience Description and Business Overview
Table 127. SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 129. SK Bioscience Recent Developments/Updates
Table 130. Walvax Biotechnology Corporation Information
Table 131. Walvax Biotechnology Description and Business Overview
Table 132. Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 134. Walvax Biotechnology Recent Developments/Updates
Table 135. Eli Lilly Corporation Information
Table 136. Eli Lilly Description and Business Overview
Table 137. Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 139. Eli Lilly Recent Developments/Updates
Table 140. Abera Corporation Information
Table 141. Abera Description and Business Overview
Table 142. Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 144. Abera Recent Developments/Updates
Table 145. Sanofi Corporation Information
Table 146. Sanofi Description and Business Overview
Table 147. Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 149. Sanofi Recent Developments/Updates
Table 150. Genentech Corporation Information
Table 151. Genentech Description and Business Overview
Table 152. Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product
Table 154. Genentech Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Distributors List
Table 158. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Customers List
Table 159. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Trends
Table 160. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Drivers
Table 161. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Challenges
Table 162. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Figure 2. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Share by Type in 2022 & 2034
Figure 4. 9-Valent Product Picture
Figure 5. 13-Valent Product Picture
Figure 6. 23-Valent Product Picture
Figure 7. Others Product Picture
Figure 8. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Share by Application in 2022 & 2034
Figure 10. Hospital
Figure 11. Community Clinics
Figure 12. Public Health Agencies
Figure 13. Others
Figure 14. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size (2024-2034) & (US$ Million)
Figure 16. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (2024-2034) & (K Units)
Figure 17. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Average Price (US$/Unit) & (2024-2034)
Figure 18. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Report Years Considered
Figure 19. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Share by Manufacturers in 2022
Figure 20. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Players: Market Share by Revenue in 2022
Figure 22. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 23. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 24. North America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country (2024-2034)
Figure 25. North America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country (2024-2034)
Figure 26. United States Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Canada Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country (2024-2034)
Figure 29. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country (2024-2034)
Figure 30. Germany Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. France Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. U.K. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Italy Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Russia Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Asia Pacific Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Region (2024-2034)
Figure 36. Asia Pacific Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Region (2024-2034)
Figure 37. China Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Japan Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. South Korea Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. India Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Australia Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. China Taiwan Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Southeast Asia Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Latin America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country (2024-2034)
Figure 45. Latin America Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country (2024-2034)
Figure 46. Mexico Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Brazil Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Argentina Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country (2024-2034)
Figure 50. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country (2024-2034)
Figure 51. Turkey Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. UAE Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Type (2024-2034)
Figure 55. Global Revenue Market Share of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Type (2024-2034)
Figure 56. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Price (US$/Unit) by Type (2024-2034)
Figure 57. Global Sales Market Share of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Application (2024-2034)
Figure 58. Global Revenue Market Share of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Application (2024-2034)
Figure 59. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Price (US$/Unit) by Application (2024-2034)
Figure 60. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Value Chain
Figure 61. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed